Atrial fibrillation is a risk marker for worse in-hospital and long-term outcome in patients with peripheral artery disease

International Journal of Cardiology - Tập 199 - Trang 223-228 - 2015
Kristina Wasmer1, Michael Unrath2, Julia Köbe1, Nasser M. Malyar3, Eva Freisinger3, Matthias Meyborg3, Günter Breithardt1, Lars Eckardt1, Holger Reinecke3
1Division of Clinical and Experimental Electrophysiology, Department of Cardiovascular Medicine, University Hospital Münster, Germany
2Department of New Public Health, School of Human Sciences, Osnabrück University, Osnabrück, Germany
3Division of Vascular Medicine, Department of Cardiovascular Medicine, University Hospital Münster, Germany

Tài liệu tham khảo

ACTIVE Writing Group of the ACTIVE Investigators, 2006, Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (active w): a randomised controlled trial, Lancet, 367, 1903, 10.1016/S0140-6736(06)68845-4

ACTIVE Investigators, 2009, Effect of clopidogrel added to aspirin in patients with atrial fibrillation, N. Engl. J. Med., 360, 2066, 10.1056/NEJMoa0901301

Kannel, 1982, Epidemiologic features of chronic atrial fibrillation: the Framingham study, N. Engl. J. Med., 306, 1018, 10.1056/NEJM198204293061703

Benjamin, 1998, Impact of atrial fibrillation on the risk of death: the Framingham heart study, Circulation, 98, 946, 10.1161/01.CIR.98.10.946